For citations:
Avdeeva A.S., Aleksandrova E.N., Karateev D.E., Luchikhina E.L., Cherkasova M.V., Nasonov E.L. ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL. Rheumatology Science and Practice. 2016;54(1):38-43. (In Russ.) https://doi.org/10.14412/1995-4484-2016-38-43
Email this article 